The responsibility to pay for cancer treatments: A health insurer's view of value.
Newcomer
Lee N
LN
UnitedHealthcare, Edina, Minnesota 55436, USA. lee_newcomer@uhc.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D017598:Efficiency, Organizational / Q000592:standards; D005260:Female; D006801:Humans; D007343:Insurance Carriers / Q000592:standards; D007348:Insurance, Health / Q000191:economics / Q000331:legislation & jurisprudence; D007351:Insurance, Liability / Q000191:economics / Q000331:legislation & jurisprudence; D008910:Minnesota; D009369:Neoplasms / Q000191:economics* / Q000628:therapy*; D010816:Physician Incentive Plans / Q000458:organization & administration
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab